Autolus Therapeutics plc Market Cap 2011-2026 | AUTL

As of March 02, 2026 Autolus Therapeutics plc has a market cap of $ 429 M

Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.^[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Autolus Therapeutics plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
424 M	1.09 B	299 M	270 M	332 M	352 M	1.08 B	43.4 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.09 B	43.4 M	485 M

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer	Market Cap	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	315 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	12.1 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	127 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	33.6 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	14.1 K	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	549 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	724 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	32.8 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	28.9 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	79 M	-	-18.52 %	$ 27.3 M	Britain
ARCA biopharma ABIO	484 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	16.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	40.7 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	76.4 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	2.83 B	-	-	-	Russia
AIkido Pharma AIKI	19.6 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	3.25 B	-	-	$ 3.67 B	USA
Akouos AKUS	172 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	538 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	71.4 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	38.2 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	49 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	269 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	41.4 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	664 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	22.1 M	-	-	$ 10.1 M	USA
Aravive ARAV	60.4 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	2.32 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	9.48 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	16.2 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	4.13 M	-	17.91 %	$ 11.1 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	3.53 B	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	544 K	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	364 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	25 M	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	81.2 B	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	98 M	-	-	$ 521 M	USA
Atreca BCEL	49 M	-	-11.76 %	$ 5.79 M	USA
AVROBIO AVRO	56.3 M	-	1083.1 %	$ 745 M	USA
Agenus AGEN	215 K	$ 3.27	-1.8 %	$ 1.17 M	USA
Ayala Pharmaceuticals AYLA	7.72 M	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	1.63 B	$ 28.72	-5.0 %	$ 1.66 B	USA
bluebird bio BLUE	67 M	-	-	$ 546 M	USA
Brickell Biotech BBI	11.4 M	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	1.87 M	-	-9.65 %	$ 45.9 M	USA
Завод ДИОД DIOD	661 M	-	-	-	Russia
Фармсинтез LIFE	2 B	-	-	-	Russia
Baudax Bio BXRX	779 K	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	960 M	-	-10.95 %	$ 876 K	USA